Romana Khursheed, Jayanth Shivalingappa, Arif Maldar, A. Dalal
{"title":"印度南部一家三级医院妊娠期高血糖的患病率、临床概况和孕产妇及围产期结局","authors":"Romana Khursheed, Jayanth Shivalingappa, Arif Maldar, A. Dalal","doi":"10.4103/jss.jss_65_22","DOIUrl":null,"url":null,"abstract":"Background: Hyperglycemia in pregnancy (HIP) is an umbrella term for any degree of carbohydrate intolerance in pregnancy which carries risk of transgenerational transfer of metabolic disorders. The present observational study was carried out to know the prevalence, clinical profile, and maternal and perinatal outcome in different categories of HIP, in a South Indian setup. Materials and Methods: The study was carried out for 1 year at KAHER's Dr Prabhakar Kore Charitable Hospital, Belagavi in South India. The HIP was diagnosed by Diabetes in Pregnancy Study Group of India criteria and further categorized into gestational diabetes mellitus (GDM), gestational glucose intolerance (GGI), and diabetes in pregnancy (DIP). The prevalence, clinical profile, and maternal and perinatal outcome were analyzed in three groups. Results: The prevalence of HIP among pregnant population was found to be 17.47% in 1 year. 222 women (75.5%) had GDM, followed by 49 (17%) and 23 women (8%) presented with GGI and DIP, respectively. The maternal outcomes among HIP were cesarean delivery 230 (78.2), preterm labor 53 (18.02%), preeclampsia 50 (17.01%), premature rupture of membranes 34 (11.56%), and infections 33 (11.22%). The perinatal outcome recorded were neonatal intensive care unit admissions in 107 neonates (36.39%), hyperbilirubinemia in 44 neonates (15%), hypoglycemia in 79 neonates (26.8%), respiratory distress syndrome in 43 neonates (14.46%), and macrosomia in 44 fetuses (15%). Conclusion: Degree of hyperglycemia affects pregnancy outcomes. Continued surveillance of women in preconceptional, antenatal, and postnatal period ensures early diagnosis and management of glucose intolerance and helps in delaying the onset of overt diabetes.","PeriodicalId":55681,"journal":{"name":"Journal of the Scientific Society","volume":null,"pages":null},"PeriodicalIF":0.1000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prevalence, clinical profile, and maternal and perinatal outcomes of hyperglycemia in pregnancy in a tertiary care hospital in South India\",\"authors\":\"Romana Khursheed, Jayanth Shivalingappa, Arif Maldar, A. Dalal\",\"doi\":\"10.4103/jss.jss_65_22\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Hyperglycemia in pregnancy (HIP) is an umbrella term for any degree of carbohydrate intolerance in pregnancy which carries risk of transgenerational transfer of metabolic disorders. The present observational study was carried out to know the prevalence, clinical profile, and maternal and perinatal outcome in different categories of HIP, in a South Indian setup. Materials and Methods: The study was carried out for 1 year at KAHER's Dr Prabhakar Kore Charitable Hospital, Belagavi in South India. The HIP was diagnosed by Diabetes in Pregnancy Study Group of India criteria and further categorized into gestational diabetes mellitus (GDM), gestational glucose intolerance (GGI), and diabetes in pregnancy (DIP). The prevalence, clinical profile, and maternal and perinatal outcome were analyzed in three groups. Results: The prevalence of HIP among pregnant population was found to be 17.47% in 1 year. 222 women (75.5%) had GDM, followed by 49 (17%) and 23 women (8%) presented with GGI and DIP, respectively. The maternal outcomes among HIP were cesarean delivery 230 (78.2), preterm labor 53 (18.02%), preeclampsia 50 (17.01%), premature rupture of membranes 34 (11.56%), and infections 33 (11.22%). The perinatal outcome recorded were neonatal intensive care unit admissions in 107 neonates (36.39%), hyperbilirubinemia in 44 neonates (15%), hypoglycemia in 79 neonates (26.8%), respiratory distress syndrome in 43 neonates (14.46%), and macrosomia in 44 fetuses (15%). Conclusion: Degree of hyperglycemia affects pregnancy outcomes. Continued surveillance of women in preconceptional, antenatal, and postnatal period ensures early diagnosis and management of glucose intolerance and helps in delaying the onset of overt diabetes.\",\"PeriodicalId\":55681,\"journal\":{\"name\":\"Journal of the Scientific Society\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.1000,\"publicationDate\":\"2022-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the Scientific Society\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/jss.jss_65_22\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Scientific Society","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jss.jss_65_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
摘要
背景:妊娠期高血糖症(HIP)是妊娠期任何程度的碳水化合物不耐受的总称,具有代谢性疾病代际转移的风险。本观察性研究旨在了解南印度不同类型HIP的患病率、临床概况以及孕产妇和围产期结局。材料和方法:该研究在印度南部Belagavi的KAHER Dr Prabhakar Kore慈善医院进行了1年。根据印度妊娠期糖尿病研究组的诊断标准,HIP进一步分为妊娠期糖尿病(GDM)、妊娠期葡萄糖耐受不良(GGI)和妊娠期糖尿病(DIP)。对三组患者的患病率、临床情况、母婴结局进行分析。结果:妊娠人群1年内髋关节置放率为17.47%。222名妇女(75.5%)患有GDM, 49名妇女(17%)和23名妇女(8%)分别患有GGI和DIP。产妇结局为剖宫产230例(78.2),早产53例(18.02%),先兆子痫50例(17.01%),胎膜早破34例(11.56%),感染33例(11.22%)。围产期结局为新生儿重症监护病房住院107例(36.39%),高胆红素血症44例(15%),低血糖79例(26.8%),呼吸窘迫综合征43例(14.46%),巨大儿44例(15%)。结论:高血糖程度影响妊娠结局。在孕前、产前和产后对妇女进行持续监测,确保对葡萄糖耐受不良的早期诊断和管理,并有助于延缓显性糖尿病的发病。
Prevalence, clinical profile, and maternal and perinatal outcomes of hyperglycemia in pregnancy in a tertiary care hospital in South India
Background: Hyperglycemia in pregnancy (HIP) is an umbrella term for any degree of carbohydrate intolerance in pregnancy which carries risk of transgenerational transfer of metabolic disorders. The present observational study was carried out to know the prevalence, clinical profile, and maternal and perinatal outcome in different categories of HIP, in a South Indian setup. Materials and Methods: The study was carried out for 1 year at KAHER's Dr Prabhakar Kore Charitable Hospital, Belagavi in South India. The HIP was diagnosed by Diabetes in Pregnancy Study Group of India criteria and further categorized into gestational diabetes mellitus (GDM), gestational glucose intolerance (GGI), and diabetes in pregnancy (DIP). The prevalence, clinical profile, and maternal and perinatal outcome were analyzed in three groups. Results: The prevalence of HIP among pregnant population was found to be 17.47% in 1 year. 222 women (75.5%) had GDM, followed by 49 (17%) and 23 women (8%) presented with GGI and DIP, respectively. The maternal outcomes among HIP were cesarean delivery 230 (78.2), preterm labor 53 (18.02%), preeclampsia 50 (17.01%), premature rupture of membranes 34 (11.56%), and infections 33 (11.22%). The perinatal outcome recorded were neonatal intensive care unit admissions in 107 neonates (36.39%), hyperbilirubinemia in 44 neonates (15%), hypoglycemia in 79 neonates (26.8%), respiratory distress syndrome in 43 neonates (14.46%), and macrosomia in 44 fetuses (15%). Conclusion: Degree of hyperglycemia affects pregnancy outcomes. Continued surveillance of women in preconceptional, antenatal, and postnatal period ensures early diagnosis and management of glucose intolerance and helps in delaying the onset of overt diabetes.